ArticleAntimicrobial agents and chemotherapy2010

Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.

Koné Kaniga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.